{"id":1056,"date":"2019-11-15T10:27:17","date_gmt":"2019-11-15T10:27:17","guid":{"rendered":"https:\/\/closerleukemia.eu\/resumen\/"},"modified":"2019-12-17T22:52:43","modified_gmt":"2019-12-17T22:52:43","slug":"resumen","status":"publish","type":"page","link":"https:\/\/closerleukemia.eu\/es\/resumen\/","title":{"rendered":"Resumen"},"content":{"rendered":"<p>[vc_row row_type=\u00bbparallax\u00bb parallax_content_width=\u00bbin_grid\u00bb text_align=\u00bbleft\u00bb full_screen_section_height=\u00bbno\u00bb background_image=\u00bb154&#8243;][vc_column][vc_empty_space height=\u00bb200px\u00bb][vc_row_inner row_type=\u00bbrow\u00bb type=\u00bbgrid\u00bb text_align=\u00bbleft\u00bb css_animation=\u00bb\u00bb][vc_column_inner width=\u00bb1\/2&#8243;][vc_column_text]<\/p>\n<h1><span style=\"color: #e83b6a;\">RESUMEN<\/span><\/h1>\n<p>&nbsp;<\/p>\n<h3>El c\u00e1ncer constituye un importante problema de Salud P\u00fablica a nivel mundial y las desigualdades en el acceso a su control provocan diferencias en el pron\u00f3stico de los pacientes.<\/h3>\n<p>&nbsp;<\/p>\n<h3>A pesar de la mejor\u00eda de las tasas de supervivencia de la leucemia pedi\u00e1trica en los \u00faltimos a\u00f1os, todav\u00eda hay diferencias en la supervivencia entre regiones, incluso dentro de grupos cooperativos internacionales bien organizados.<span class=\"Apple-converted-space\">\u00a0<\/span><\/h3>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/2&#8243;][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=\u00bb200px\u00bb][\/vc_column][\/vc_row][vc_row css_animation=\u00bb\u00bb row_type=\u00bbrow\u00bb use_row_as_full_screen_section=\u00bbno\u00bb type=\u00bbfull_width\u00bb angled_section=\u00bbno\u00bb text_align=\u00bbleft\u00bb background_image_as_pattern=\u00bbwithout_pattern\u00bb][vc_column][vc_empty_space height=\u00bb70px\u00bb][vc_row_inner row_type=\u00bbrow\u00bb type=\u00bbgrid\u00bb text_align=\u00bbleft\u00bb css_animation=\u00bb\u00bb][vc_column_inner width=\u00bb1\/2&#8243;][vc_column_text css=\u00bb.vc_custom_1567162616822{padding-top: 40px !important;padding-right: 40px !important;padding-bottom: 40px !important;padding-left: 40px !important;background-color: #e83b6a !important;background-position: center !important;background-repeat: no-repeat !important;background-size: contain !important;}\u00bb]<\/p>\n<h4><span style=\"color: #ffffff;\">CLOSER pretende armonizar el manejo de la leucemia infantil y reducir las desigualdades existentes en el pron\u00f3stico de los pacientes de Sudam\u00e9rica y Europa. Para ello, crearemos un marco de investigaci\u00f3n colaborativa y multidisciplinar entre ambas regiones.<\/span><\/h4>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/2&#8243;][vc_empty_space height=\u00bb40px\u00bb][vc_column_text css=\u00bb.vc_custom_1567162724173{padding-top: 40px !important;padding-right: 40px !important;padding-bottom: 40px !important;padding-left: 40px !important;background-color: #ffffff !important;background-position: center !important;background-repeat: no-repeat !important;background-size: contain !important;}\u00bb]<\/p>\n<h4>El manejo de la leucemia infantil deber\u00eda abordarse desde un punto de vista global,<\/h4>\n<p>&nbsp;<\/p>\n<p>considerando no solo los aspectos cient\u00edficos, la cantidad de recursos humanos y tecnol\u00f3gicos y las actuales pol\u00edticas de salud, sino tambi\u00e9n las particularidades econ\u00f3micas, culturales, sociales y geogr\u00e1ficas que existen entre pa\u00edses.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=\u00bb70px\u00bb][\/vc_column][\/vc_row][vc_row css_animation=\u00bb\u00bb row_type=\u00bbrow\u00bb use_row_as_full_screen_section=\u00bbno\u00bb type=\u00bbgrid\u00bb angled_section=\u00bbno\u00bb text_align=\u00bbcenter\u00bb background_image_as_pattern=\u00bbwithout_pattern\u00bb z_index=\u00bb\u00bb background_color=\u00bb#ffffff\u00bb][vc_column width=\u00bb1\/6&#8243;][\/vc_column][vc_column width=\u00bb2\/3&#8243;][vc_empty_space height=\u00bb70px\u00bb][vc_single_image image=\u00bb1059&#8243; img_size=\u00bbfull\u00bb alignment=\u00bbcenter\u00bb qode_css_animation=\u00bb\u00bb][vc_empty_space height=\u00bb70px\u00bb][vc_column_text]<\/p>\n<p style=\"text-align: center;\"><span class=\"Apple-converted-space\">Para abordar la leucemia infantil desde una perspectiva integral, incluiremos como socios del proyecto a investigadores, m\u00e9dicos, pacientes y familias, autoridades sanitarias, pol\u00edticos, peque\u00f1as y medianas empresas y representantes de la sociedad civil. <\/span><\/p>\n<p>&nbsp;<\/p>\n<h4 style=\"text-align: center;\">CLOSER permitir\u00e1 una colaboraci\u00f3n mundial m\u00e1s fluida para mejorar el control de la leucemia infantil.<\/h4>\n<p>[\/vc_column_text][vc_empty_space height=\u00bb30px\u00bb]<a  itemprop=\"url\" href=\"https:\/\/closerleukemia.eu\/es\/mision\/\" target=\"_self\"  class=\"qbutton  default\" style=\"margin: 5px 5px 5px 5px; \">Misi\u00f3n<\/a><a  itemprop=\"url\" href=\"https:\/\/closerleukemia.eu\/es\/socios\/\" target=\"_self\"  class=\"qbutton  default\" style=\"margin: 5px 5px 5px 5px; \">Socios<\/a>[vc_empty_space height=\u00bb70px\u00bb][\/vc_column][vc_column width=\u00bb1\/6&#8243;][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row row_type=\u00bbparallax\u00bb parallax_content_width=\u00bbin_grid\u00bb text_align=\u00bbleft\u00bb full_screen_section_height=\u00bbno\u00bb background_image=\u00bb154&#8243;][vc_column][vc_empty_space height=\u00bb200px\u00bb][vc_row_inner row_type=\u00bbrow\u00bb type=\u00bbgrid\u00bb text_align=\u00bbleft\u00bb css_animation=\u00bb\u00bb][vc_column_inner width=\u00bb1\/2&#8243;][vc_column_text] RESUMEN &nbsp; El c\u00e1ncer constituye un importante problema de Salud P\u00fablica a nivel mundial y las desigualdades en el acceso a su control provocan diferencias en el pron\u00f3stico de los pacientes. &nbsp; A&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full_width.php","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-1056","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/closerleukemia.eu\/es\/wp-json\/wp\/v2\/pages\/1056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/closerleukemia.eu\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/closerleukemia.eu\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/closerleukemia.eu\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/closerleukemia.eu\/es\/wp-json\/wp\/v2\/comments?post=1056"}],"version-history":[{"count":10,"href":"https:\/\/closerleukemia.eu\/es\/wp-json\/wp\/v2\/pages\/1056\/revisions"}],"predecessor-version":[{"id":1238,"href":"https:\/\/closerleukemia.eu\/es\/wp-json\/wp\/v2\/pages\/1056\/revisions\/1238"}],"wp:attachment":[{"href":"https:\/\/closerleukemia.eu\/es\/wp-json\/wp\/v2\/media?parent=1056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}